Longeveron Inc. - LGVN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 05, 2026 | Chief Financial Officer | F | D | 742.0 | 2.59 | 1,921.78 | 29,258.0 | View | |
| Oct 05, 2026 | Chief Executive Officer | F | D | 1,987.0 | 2.59 | 5,146.33 | 74,916.0 | View | |
| Oct 05, 2026 | Chief Medical Officer | F | D | 2,913.0 | 2.59 | 7,544.67 | 68,778.0 | View | |
| Oct 05, 2026 | General Counsel, Secretary | F | D | 2,253.0 | 2.59 | 5,835.27 | 83,889.0 | View | |
| Oct 05, 2026 | CTO & SVP of CMC | F | D | 2,520.0 | 2.59 | 6,526.8 | 68,653.0 | View | |
| Aug 25, 2026 | Chief Financial Officer | A | A | 300,000.0 | 0.0 | 0.0 | 300,000.0 | View | |
| Aug 21, 2026 | General Counsel, Secretary | A | A | 286,000.0 | 0.0 | 0.0 | 861,423.0 | View | |
| Aug 21, 2026 | — | A | A | 36,000.0 | 0.0 | 0.0 | 69,000.0 | View | |
| Aug 21, 2026 | — | A | A | 36,000.0 | 0.0 | 0.0 | 262,034.0 | View | |
| Aug 21, 2026 | — | A | A | 36,000.0 | 0.0 | 0.0 | 70,000.0 | View | |
| Aug 21, 2026 | — | A | A | 36,000.0 | 0.0 | 0.0 | 77,000.0 | View | |
| Aug 21, 2026 | — | A | A | 36,000.0 | 0.0 | 0.0 | 36,000.0 | View | |
| Aug 21, 2026 | — | A | A | 36,000.0 | 0.0 | 0.0 | 36,000.0 | View | |
| Aug 21, 2026 | CTO & SVP of CMC | A | A | 286,000.0 | 0.0 | 0.0 | 711,735.0 | View | |
| Aug 21, 2026 | — | A | A | 36,000.0 | 0.0 | 0.0 | 36,000.0 | View | |
| Aug 21, 2026 | Chief Medical Officer | A | A | 286,000.0 | 0.0 | 0.0 | 716,914.0 | View | |
| Aug 21, 2026 | Chief Scientific Officer | A | A | 286,000.0 | 0.0 | 0.0 | 1,607,796.0 | View | |
| Jul 08, 2026 | Chief Scientific Officer | A | A | 400,000.0 | 0.0 | 0.0 | 400,000.0 | View | |
| Jul 08, 2026 | Chief Scientific Officer | A | A | 600,000.0 | 0.0 | 0.0 | 1,321,796.0 | View | |
| Jul 06, 2026 | Chief Executive Officer | F | D | 18,046.0 | 0.7291 | 13,157.34 | 771,681.0 | View | |
| Jul 06, 2026 | Chief Financial Officer | F | D | 22,505.0 | 0.7291 | 16,408.4 | 443,181.0 | View | |
| Jul 06, 2026 | Chief Medical Officer | F | D | 22,505.0 | 0.7291 | 16,408.4 | 430,914.0 | View | |
| Jul 06, 2026 | CTO & SVP of CMC | F | D | 15,808.0 | 0.7291 | 11,525.61 | 425,735.0 | View | |
| Jul 06, 2026 | General Counsel, Secretary | F | D | 13,143.0 | 0.7291 | 9,582.56 | 575,423.0 | View | |
| May 05, 2026 | General Counsel, Secretary | A | A | 250,000.0 | 0.0 | 0.0 | 588,566.0 | View | |
| May 05, 2026 | Chief Executive Officer | A | A | 500,000.0 | 0.0 | 0.0 | 789,727.0 | View | |
| May 05, 2026 | CTO & SVP of CMC | A | A | 250,000.0 | 0.0 | 0.0 | 441,543.0 | View | |
| May 05, 2026 | Chief Medical Officer | A | A | 250,000.0 | 0.0 | 0.0 | 453,419.0 | View | |
| May 05, 2026 | Chief Financial Officer | A | A | 250,000.0 | 0.0 | 0.0 | 465,686.0 | View |